Alpha-lipoic acid for IVF in women 35-45
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether taking alpha-lipoic acid (an antioxidant supplement) before and during IVF can improve pregnancy success in women aged 35–45 using their own eggs. It aims to see if the supplement can help counter age-related declines in egg quality.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 35 and 45
- Your body mass index (BMI) is between 18 and 35
- You plan to use your own eggs for IVF treatment
- You do not have a known allergy to alpha-lipoic acid
- You do not have very low egg reserve (primary ovarian insufficiency) or severe uterus problems
- Neither you nor your partner has a known chromosomal condition or active cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial tests two forms of coenzyme Q10 (ubiquinone vs. ubiquinol) to see if either improves egg quality or IVF success. It may be a good fit if you are between 37 and 43, doing your first IVF cycle, and have certain hormone levels within a normal range.
This study tests whether taking coenzyme Q10 before in vitro fertilization (IVF) can improve egg quality and increase the chances of a successful pregnancy for women with a low ovarian response. It may help if you have had few eggs retrieved in past IVF cycles or have low ovarian reserve.
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial tests whether taking testosterone before IVF can improve egg quality and pregnancy chances in women with low ovarian reserve. It is specifically for women with a certain genetic marker in the androgen receptor.
Hear when a new Female Infertility Due to Diminished Ovarian Reserve trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.